18 results with keyword: 'safinamide for the treatment of parkinson s disease'
Randomized trial of safinamide add-on to levodopa in Parkinson’s disease with motor fluctuations. Borgohain R, Szasz J, Stanzione P,
N/A
Safinamide as monotherapy and as an adjunct to dopamine agonists improves Unified Parkinson’s Disease Rating Scale motor scores.. One randomized, placebo-controlled
N/A
Knobloch SC Introduction, November 2015 13 DDT: Main Window Process controls Process groups Source code Variables Expression evaluator Stack trace... DDT:
N/A
Randomized, double-blind, placebo-controlled, dose- finding study Monotherapy or adjunct therapy to stable single DA 172 early PD patients (56 per group of treatment) Proportion
N/A
Post hoc analysis showed the 100mg/day dose was associated with lowered intervention rate with dopamine therapy and improved UPDRS scores (secondary outcomes)
N/A
The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are
N/A
Reduction of LD dose possible Few dropouts and no safety concerns SETTLE efficacy and safety of S (NCT00627640) [80,81] Phase III PC 24 weeks 549 50 100 Advanced PD: add-on therapy to
N/A
Safinamide as an add-on therapy to a stable dose of a single dopamine agonist: results from a randomized, placebo-controlled, 24-week multicenter trial in early
N/A
future investigations have the potential to further clar- ify underlying mechanisms of speech disorders in PD while addressing key variables for improving speech treatment
N/A
- This report provides you with a breakdown of market data including data on number of active policies, gross written premiums and insurance penetration percentage.. - This
N/A
Higher load of dopaminergic treatment may be related to the hallucinations, but disease severity, cognitive impairment, depression, older age and worse visual acuity may also
N/A
two valid reasons.. MHSS/ECO 12/MIDTERM-2019 Page 3 iii) Use the given information to answer the given questions.. Why total fixed cost curve in the diagram originates from A and
N/A
Safinamide as an addon therapy to a stable dose of a single dopamine agonist: results from a randomized, placebocontrolled, 24week multicenter trial in early idio pathic
N/A
• suffers at least a 20% reduction in capacity to earn their pre-disability income, regardless as to whether they can or cannot perform any income producing duties, and is actually
N/A
When the DIR-412 is in 3G router mode, LAN clients can access the DIR-412 via the DIR-412’s Ethernet connection, as well as via the wireless connection.... 7 D-Link DIR-412
N/A
- FDI in Kosovo in 2007 reached the highest amount of investment which in the years that followed came to halt, and according to the analysis of expected that in the coming years
N/A
This document contains forward-looking statements, including (without limitation) about (1) Newron’s ability to develop and expand its business, successfully complete development
N/A